Meling Biomedical – “Preserving Life with Advanced Science”

Meling Biomedical, a core subsidiary of Changhong Group—China’s leading home appliance and technology conglomerate—has been dedicated to the research, design, manufacturing, and global distribution of cryogenic and biomedical storage solutions since its founding in 2002.

Leveraging Changhong Group’s deep-rooted manufacturing legacy and cutting-edge innovation platform (established in 1958 and headquartered in Mianyang, Sichuan), Meling Biomedical integrates advanced refrigeration technologies with the evolving needs of the life sciences. This synergy has enabled the company to develop a diverse, high-performance product portfolio that meets the demanding requirements of biomedical laboratories, research institutions, healthcare providers, and public health systems worldwide.

Capital Market Recognition

A major milestone in the company’s growth came in 2022 with its successful listing on the Beijing Stock Exchange (BSE). This achievement established Meling Biomedical as the first BSE-listed company in Anhui Province, while also setting a record for speed: the listing process was completed in just 111 days, with review approval granted within only 37 days. These milestones reflect the company’s operational excellence, robust governance, and strong market confidence.

Innovation-Driven Excellence

Over two decades, Meling Biomedical has cultivated a world-class R&D team responsible for nearly 500 proprietary scientific innovations, including both invention and utility model patents. One standout achievement is the nationally awarded “New Mixed Working Medium Throttling Refrigeration Technology and Its Application,” which earned the Second Prize for National Technical Invention and First Prize from the China Refrigeration Society—affirming the company's leadership in refrigeration science and engineering.

Comprehensive, Intelligent Solutions

With a strong commitment to user-centric innovation, Meling Biomedical offers customized, intelligent solutions across multiple fields:

Biobanks & Sample Storage
Blood Safety & Vaccine Preservation
Pharmaceutical Cold Chain
IoT-Enabled LN2 Storage Systems
Secure Laboratory & Research Facility Storage
These solutions are engineered with a focus on safety, reliability, and environmental sustainability. Meling products are used globally in hospitals, CDCs, academic institutions, public health facilities, scientific laboratories, genetic engineering centers, and the animal health sector.

Advanced Infrastructure & Global Reach

Meling’s R&D facility covers over 5,000 square meters, with manufacturing and testing facilities spanning more than 85,000 square meters. These include fully automated low-temperature equipment production lines, type laboratories, and a comprehensive testing and pilot-scale workshop. Combined with a full-service global support infrastructure and international certifications, Meling products are now exported to over 90 countries across Europe, the Americas, Asia-Pacific, the Middle East, and Africa.

Looking Ahead

Meling Biomedical remains firmly committed to continuous product innovation, expansion of category offerings, and sustainable development. With a strategic focus on green technologies, energy-efficient designs, and diversified global trade models, the company aims to make a lasting contribution to human health and environmental protection.

Meling Biomedical – “Preserving Life with Advanced Science”.
We are committed to becoming the global leader in customized biomedical system solutions.